AKOYA BIOSCIENCES, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.9 USD | +3.94% |
|
-35.27% | -40.57% |
| May. 15 | Piper Sandler Cuts Akoya Biosciences Price Target to $6 From $8, Maintains Overweight Rating | MT |
| May. 14 | Top Midday Decliners | MT |
Presenter SpeechJohn Sourbeer (Analysts)[Audio Gap]
the birth of ...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Akoya Biosciences, Inc. is a life sciences technology company delivering spatial biology solutions focused on transforming discovery, clinical research, and diagnostics. It offers single-cell imaging solutions that allow researchers to phenotype cells with spatial context and visualize how they organize and interact to influence disease progression and response to therapy. It offers a full continuum of spatial phenotyping solutions to serve the diverse needs of researchers across discovery, translational and clinical research: PhenoCode Panels and PhenoCycler, PhenoImager Fusion and PhenoImager HT Instruments. Its PhenoCycler platform provides ultra-high parameter biomarker discovery, with the ability to analyze high-plex single-cell resolution across the entire tissue sample. Its PhenoImager platform enables researchers to visualize, analyze, quantify and phenotype cells in situ, in fresh frozen or formalin-fixed paraffin-embedded (FFPE) tissue sections, and tissue microarrays (TMAs).
Calendar
2024-06-04
- Annual General Meeting
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
2.9
USD
Average target price
7.429
USD
Spread / Average Target
+156.16%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -40.57% | 138M | |
| +12.50% | 229B | |
| +14.52% | 195B | |
| +17.51% | 142B | |
| +28.96% | 109B | |
| +3.27% | 64.85B | |
| +18.16% | 54.33B | |
| +7.63% | 52.09B | |
| +10.95% | 45.15B | |
| +5.10% | 37.39B |
- Stock Market
- Equities
- AKYA Stock
- News Akoya Biosciences, Inc.
- Transcript : Akoya Biosciences, Inc. Presents at UBS Global Healthcare Conference, May-23-2022 07
